Insider · CIK 0001053878
JOHNSON LORIN K
Reports to the SEC for 2 companies · RALEIGH, NC
Transactions
23
Companies
2
Filings
14
CIK
0001053878
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2023-03-29 | 9 METERS BIOPHARMA, INC.A Award | — |
| 2022-06-22 | 9 METERS BIOPHARMA, INC.Stock Option (Right to Buy)A Award | — |
| 2022-02-28 | EDSAEdesa Biotech, Inc. · Stock Option (right to buy)A Award | — |
| 2021-06-22 | 9 METERS BIOPHARMA, INC.Stock Option (Right to Buy)A Award | — |
| 2021-04-22 | EDSAEdesa Biotech, Inc. · Stock Option (right to buy)A Award | — |
| 2020-11-09 | EDSAEdesa Biotech, Inc.X Exercise of In-Money | +$17K |
| 2020-11-09 | EDSAEdesa Biotech, Inc. · Common Share Warrants (Right to Buy)X Exercise of In-Money | — |
| 2020-10-13 | EDSAEdesa Biotech, Inc. · Stock option (right to buy)A Award | — |
| 2020-07-06 | 9 METERS BIOPHARMA, INC.Stock Option (Right to Buy)A Award | — |
| 2020-06-30 | 9 METERS BIOPHARMA, INC.C Conversion | — |
| 2020-06-30 | 9 METERS BIOPHARMA, INC.Series A Convertible Preferred StockC Conversion | — |
| 2020-05-04 | 9 METERS BIOPHARMA, INC.Series A Convertible Preferred StockP Purchase | — |
| 2020-05-04 | 9 METERS BIOPHARMA, INC.Series A Convertible Preferred WarrantP Purchase | — |
| 2020-04-24 | 9 METERS BIOPHARMA, INC.Stock Option (Right to Buy)A Award | — |
| 2020-02-12 | EDSAEdesa Biotech, Inc. · Share Option (Right to Buy)A Award | — |
| 2020-01-08 | EDSAEdesa Biotech, Inc. · Common Share Warrants (Right to Buy)P Purchase | — |
| 2020-01-08 | EDSAEdesa Biotech, Inc.A Award | +$35K |
| 2020-01-08 | EDSAEdesa Biotech, Inc. · Common Share Warrants (Right to Buy)A Award | — |
| 2020-01-08 | EDSAEdesa Biotech, Inc. · Common Share Warrants (Right to Buy)A Award | — |
| 2020-01-08 | EDSAEdesa Biotech, Inc.P Purchase | +$35K |
| 2020-01-08 | EDSAEdesa Biotech, Inc. · Common Share Warrants (Right to Buy)P Purchase | — |
| 2019-05-31 | 9 METERS BIOPHARMA, INC.Stock Option (Right to Buy)A Award | — |
| 2018-12-04 | 9 METERS BIOPHARMA, INC.Stock Option (Right to Buy)A Award | — |
Recent filings
- 4JOHNSON LORIN K0001578563-23-000012SEC(opens sec.gov)
- 4JOHNSON LORIN K0001551986-22-000059SEC(opens sec.gov)
- 4JOHNSON LORIN K0001654954-22-002656SEC(opens sec.gov)
- 4JOHNSON LORIN K0001551986-21-000077SEC(opens sec.gov)
- 4JOHNSON LORIN K0001654954-21-004638SEC(opens sec.gov)
- 4JOHNSON LORIN K0001654954-20-012045SEC(opens sec.gov)
- 4JOHNSON LORIN K0001654954-20-011139SEC(opens sec.gov)
- 4JOHNSON LORIN K0001551986-20-000223SEC(opens sec.gov)
- 4JOHNSON LORIN K0001551986-20-000203SEC(opens sec.gov)
- 4JOHNSON LORIN K0001551986-20-000117SEC(opens sec.gov)
- 4JOHNSON LORIN K0001551986-20-000109SEC(opens sec.gov)
- 4JOHNSON LORIN K0001654954-20-001652SEC(opens sec.gov)
- 4/AJOHNSON LORIN K0001654954-20-000335SEC(opens sec.gov)
- 4JOHNSON LORIN K0001654954-20-000267SEC(opens sec.gov)
Companies
Address
C/O INNOVATE BIOPHARMACEUTICALS, INC., 8480 HONEYCUTT ROAD, SUITE 120
RALEIGH, NC, 27615